198 related articles for article (PubMed ID: 1687463)
21. The electrically stimulated release of [3H]noradrenaline from nucleus tractus solitarii slices in vitro is modulated via mu-opioid receptors.
Arakawa K; De Jong W; Mulder AH; Versteeg DH
Eur J Pharmacol; 1991 Jan; 192(2):311-6. PubMed ID: 1674475
[TBL] [Abstract][Full Text] [Related]
22. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
Devine DP; Leone P; Pocock D; Wise RA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
[TBL] [Abstract][Full Text] [Related]
23. Opioid-receptor-mediated inhibition of [3H]dopamine but not [3H]noradrenaline release from rat mediobasal hypothalamus slices.
Heijna MH; Padt M; Hogenboom F; Schoffelmeer AN; Mulder AH
Neuroendocrinology; 1991 Aug; 54(2):118-26. PubMed ID: 1662785
[TBL] [Abstract][Full Text] [Related]
24. Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptors.
Gulya K; Pelton JT; Hruby VJ; Yamamura HI
Life Sci; 1986 Jun; 38(24):2221-9. PubMed ID: 2872570
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
Izenwasser S; Búzás B; Cox BM
J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389
[TBL] [Abstract][Full Text] [Related]
26. Blood-brain barrier permeability and bioavailability of a highly potent and mu-selective opioid receptor antagonist, CTAP: comparison with morphine.
Abbruscato TJ; Thomas SA; Hruby VJ; Davis TP
J Pharmacol Exp Ther; 1997 Jan; 280(1):402-9. PubMed ID: 8996221
[TBL] [Abstract][Full Text] [Related]
27. Endogenous opioid peptides acting at mu-opioid receptors in the dorsal horn contribute to midbrain modulation of spinal nociceptive neurons.
Budai D; Fields HL
J Neurophysiol; 1998 Feb; 79(2):677-87. PubMed ID: 9463431
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological examination of contractile responses of the guinea-pig isolated ileum produced by mu-opioid receptor antagonists in the presence of, and following exposure to, morphine.
Mundey MK; Ali A; Mason R; Wilson VG
Br J Pharmacol; 2000 Nov; 131(5):893-902. PubMed ID: 11053208
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of highly mu and delta opioid receptor selective peptides containing a photoaffinity group.
Landis G; Lui G; Shook JE; Yamamura HI; Burks TF; Hruby VJ
J Med Chem; 1989 Mar; 32(3):638-43. PubMed ID: 2537426
[TBL] [Abstract][Full Text] [Related]
30. [3H][D-Ser2(O-tert-butyl),Leu5]enkephalyl-Thr6 and [D-Ser2(O-tert-butyl),Leu5]enkephalyl-Thr6(O-tert-butyl). Two new enkephalin analogs with both a good selectivity and a high affinity toward delta-opioid binding sites.
Delay-Goyet P; Seguin C; Gacel G; Roques BP
J Biol Chem; 1988 Mar; 263(9):4124-30. PubMed ID: 2831220
[TBL] [Abstract][Full Text] [Related]
31. Central effects of the potent and highly selective mu opioid antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) in mice.
Gulya K; Kriván M; Nyolczas N; Sarnyai Z; Kovács GL
Eur J Pharmacol; 1988 Jun; 150(3):355-60. PubMed ID: 2901358
[TBL] [Abstract][Full Text] [Related]
32. Opioid effects on spinal [3H]5-hydroxytryptamine release are not related to their antinociceptive action.
Monroe PJ; Kradel BK; Smith DL; Smith DJ
Eur J Pharmacol; 1995 Jan; 272(1):51-6. PubMed ID: 7713149
[TBL] [Abstract][Full Text] [Related]
33. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
[TBL] [Abstract][Full Text] [Related]
34. Opioid actions on rat anterior cingulate cortex neurons in vitro.
Tanaka E; North RA
J Neurosci; 1994 Mar; 14(3 Pt 1):1106-13. PubMed ID: 7907137
[TBL] [Abstract][Full Text] [Related]
35. Quantitative autoradiography of [3H]CTOP binding to mu opioid receptors in rat brain.
Hawkins KN; Knapp RJ; Gehlert DR; Lui GK; Yamamura MS; Roeske LC; Hruby VJ; Yamamura HI
Life Sci; 1988; 42(25):2541-51. PubMed ID: 2898716
[TBL] [Abstract][Full Text] [Related]
36. Beta-adrenoceptor-sensitive adenylate cyclase is inhibited by activation of mu-opioid receptors in rat striatal neurons.
Van Vliet BJ; Ruuls SR; Drukarch B; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1991 Mar; 195(2):295-300. PubMed ID: 1651867
[TBL] [Abstract][Full Text] [Related]
37. Mu and delta opioid receptors inhibit serotonin release in rat hippocampus.
Passarelli F; Costa T
J Pharmacol Exp Ther; 1989 Jan; 248(1):299-305. PubMed ID: 2536429
[TBL] [Abstract][Full Text] [Related]
38. Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro.
Shook JE; Pelton JT; Wire WS; Hirning LD; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1987 Mar; 240(3):772-7. PubMed ID: 2882015
[TBL] [Abstract][Full Text] [Related]
39. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions.
Shook JE; Pelton JT; Lemcke PK; Porreca F; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1987 Jul; 242(1):1-7. PubMed ID: 2886635
[TBL] [Abstract][Full Text] [Related]
40. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
